Atraumatic Splenic Rupture in a Patient on Apixaban and Dual Antiplatelet Therapy

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Splenic rupture due to any cause is a life-threatening complication and commonly attributed to trauma. Atraumatic splenic rupture is very rarely reported, and the incidence is currently unknown. Anticoagulants and dual anti-platelet medication can increase the chances of a splenic rupture. Surgical removal of the spleen may be warranted to prevent a life-threatening bleeding. Early identification and intervention are required for most patients as only a few qualify for medical management.

Cite

CITATION STYLE

APA

Natarajan, P., Thangarasu, S., Ruck, L., Estrada, P., Gajendran, M., Renganathan, G., … Aduroja, O. (2021). Atraumatic Splenic Rupture in a Patient on Apixaban and Dual Antiplatelet Therapy. Journal of Investigative Medicine High Impact Case Reports, 9. https://doi.org/10.1177/23247096211026492

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free